ID   GPER1_RAT               Reviewed;         375 AA.
AC   O08878;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   02-OCT-2024, entry version 148.
DE   RecName: Full=G-protein coupled estrogen receptor 1;
DE   AltName: Full=Chemoattractant receptor-like 2;
DE   AltName: Full=G protein-coupled estrogen receptor 1;
DE   AltName: Full=G-protein coupled receptor 30 {ECO:0000303|PubMed:23300088};
DE   AltName: Full=G-protein coupled receptor 41;
DE   AltName: Full=Membrane estrogen receptor;
DE            Short=mER;
GN   Name=Gper1;
GN   Synonyms=Cmkrl2, Gper, Gpr30 {ECO:0000303|PubMed:23300088}, Gpr41;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=9168987; DOI=10.1006/bbrc.1997.6591;
RA   Bonini J.A., Anderson S.M., Steiner D.F.;
RT   "Molecular cloning and tissue expression of a novel orphan G protein-
RT   coupled receptor from rat lung.";
RL   Biochem. Biophys. Res. Commun. 234:190-193(1997).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16780796; DOI=10.1016/j.bbrc.2006.05.191;
RA   Funakoshi T., Yanai A., Shinoda K., Kawano M.M., Mizukami Y.;
RT   "G protein-coupled receptor 30 is an estrogen receptor in the plasma
RT   membrane.";
RL   Biochem. Biophys. Res. Commun. 346:904-910(2006).
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17872373; DOI=10.1210/en.2007-0436;
RA   Sakamoto H., Matsuda K., Hosokawa K., Nishi M., Morris J.F.,
RA   Prossnitz E.R., Kawata M.;
RT   "Expression of G protein-coupled receptor-30, a G protein-coupled membrane
RT   estrogen receptor, in oxytocin neurons of the rat paraventricular and
RT   supraoptic nuclei.";
RL   Endocrinology 148:5842-5850(2007).
RN   [4]
RP   FUNCTION.
RX   PubMed=19179659; DOI=10.1161/circresaha.108.190892;
RA   Haas E., Bhattacharya I., Brailoiu E., Damjanovic M., Brailoiu G.C.,
RA   Gao X., Mueller-Guerre L., Marjon N.A., Gut A., Minotti R., Meyer M.R.,
RA   Amann K., Ammann E., Perez-Dominguez A., Genoni M., Clegg D.J., Dun N.J.,
RA   Resta T.C., Prossnitz E.R., Barton M.;
RT   "Regulatory role of G protein-coupled estrogen receptor for vascular
RT   function and obesity.";
RL   Circ. Res. 104:288-291(2009).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=19420011; DOI=10.1677/joe-09-0066;
RA   Hazell G.G., Yao S.T., Roper J.A., Prossnitz E.R., O'Carroll A.M.,
RA   Lolait S.J.;
RT   "Localisation of GPR30, a novel G protein-coupled oestrogen receptor,
RT   suggests multiple functions in rodent brain and peripheral tissues.";
RL   J. Endocrinol. 202:223-236(2009).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20132863; DOI=10.1016/j.mce.2010.01.035;
RA   Chimento A., Sirianni R., Delalande C., Silandre D., Bois C., Ando S.,
RA   Maggiolini M., Carreau S., Pezzi V.;
RT   "17 beta-estradiol activates rapid signaling pathways involved in rat
RT   pachytene spermatocytes apoptosis through GPR30 and ER alpha.";
RL   Mol. Cell. Endocrinol. 320:136-144(2010).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=21242460; DOI=10.1161/hypertensionaha.110.161653;
RA   Gros R., Ding Q., Sklar L.A., Prossnitz E.E., Arterburn J.B.,
RA   Chorazyczewski J., Feldman R.D.;
RT   "GPR30 expression is required for the mineralocorticoid receptor-
RT   independent rapid vascular effects of aldosterone.";
RL   Hypertension 57:442-451(2011).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21354433; DOI=10.1016/j.steroids.2011.02.018;
RA   Cheng S.B., Graeber C.T., Quinn J.A., Filardo E.J.;
RT   "Retrograde transport of the transmembrane estrogen receptor, G-protein-
RT   coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the
RT   nucleus.";
RL   Steroids 76:892-896(2011).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22919059; DOI=10.1210/en.2012-1458;
RA   Almey A., Filardo E.J., Milner T.A., Brake W.G.;
RT   "Estrogen receptors are found in glia and at extranuclear neuronal sites in
RT   the dorsal striatum of female rats: evidence for cholinergic but not
RT   dopaminergic colocalization.";
RL   Endocrinology 153:5373-5383(2012).
RN   [10]
RP   ESTROGEN-BINDING, AND SUBCELLULAR LOCATION.
RX   PubMed=22306576; DOI=10.1016/j.steroids.2012.01.015;
RA   Ropero A.B., Pang Y., Alonso-Magdalena P., Thomas P., Nadal A.;
RT   "Role of ERbeta and GPR30 in the endocrine pancreas: A matter of estrogen
RT   dose.";
RL   Steroids 77:951-958(2012).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=23283935; DOI=10.1152/ajpcell.00203.2012;
RA   Gros R., Ding Q., Liu B., Chorazyczewski J., Feldman R.D.;
RT   "Aldosterone mediates its rapid effects in vascular endothelial cells
RT   through GPER activation.";
RL   Am. J. Physiol. 304:C532-C540(2013).
RN   [12]
RP   INTERACTION WITH DLG4, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=23300088; DOI=10.1074/jbc.m112.412478;
RA   Akama K.T., Thompson L.I., Milner T.A., McEwen B.S.;
RT   "Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled
RT   receptor 30 (GPR30), an estrogen receptor that can be identified in
RT   hippocampal dendritic spines.";
RL   J. Biol. Chem. 288:6438-6450(2013).
RN   [13]
RP   REVIEW, AND SUBCELLULAR LOCATION.
RX   PubMed=23822769; DOI=10.1111/jne.12071;
RA   Srivastava D.P., Evans P.D.;
RT   "GPER 1: trials and tribulations of a membrane oestrogen receptor.";
RL   J. Neuroendocrinol. 25:1219-1230(2013).
CC   -!- FUNCTION: G-protein coupled estrogen receptor that binds to 17-beta-
CC       estradiol (E2) with high affinity, leading to rapid and transient
CC       activation of numerous intracellular signaling pathways. Stimulates
CC       cAMP production, calcium mobilization and tyrosine kinase Src inducing
CC       the release of heparin-bound epidermal growth factor (HB-EGF) and
CC       subsequent transactivation of the epidermal growth factor receptor
CC       (EGFR), activating downstream signaling pathways such as PI3K/Akt and
CC       ERK/MAPK. Mediates pleiotropic functions among others in the
CC       cardiovascular, endocrine, reproductive, immune and central nervous
CC       systems. Has a role in cardioprotection by reducing cardiac hypertrophy
CC       and perivascular fibrosis in a RAMP3-dependent manner. Regulates
CC       arterial blood pressure by stimulating vasodilation and reducing
CC       vascular smooth muscle and microvascular endothelial cell
CC       proliferation. Plays a role in blood glucose homeostasis contributing
CC       to the insulin secretion response by pancreatic beta cells. Triggers
CC       mitochondrial apoptosis during pachytene spermatocyte differentiation.
CC       Stimulates uterine epithelial cell proliferation. Enhances uterine
CC       contractility in response to oxytocin. Contributes to thymic atrophy by
CC       inducing apoptosis. Attenuates TNF-mediated endothelial expression of
CC       leukocyte adhesion molecules. Promotes neuritogenesis in developing
CC       hippocampal neurons. Plays a role in acute neuroprotection against
CC       NMDA-induced excitotoxic neuronal death. Increases firing activity and
CC       intracellular calcium oscillations in luteinizing hormone-releasing
CC       hormone (LHRH) neurons. Inhibits early osteoblast proliferation at
CC       growth plate during skeletal development. Inhibits mature adipocyte
CC       differentiation and lipid accumulation. Involved in the recruitment of
CC       beta-arrestin 2 ARRB2 at the plasma membrane in epithelial cells.
CC       Functions also as a receptor for aldosterone mediating rapid regulation
CC       of vascular contractibility through the PI3K/ERK signaling pathway.
CC       Involved in cancer progression regulation. Stimulates cancer-associated
CC       fibroblast (CAF) proliferation by a rapid genomic response through the
CC       EGFR/ERK transduction pathway. Associated with EGFR, may act as a
CC       transcription factor activating growth regulatory genes (c-fos, cyclin
CC       D1). Promotes integrin alpha-5/beta-1 and fibronectin (FN) matrix
CC       assembly in breast cancer cells. {ECO:0000269|PubMed:19179659,
CC       ECO:0000269|PubMed:20132863}.
CC   -!- SUBUNIT: Homodimer (Probable). Heterodimer; heterodimerizes with other
CC       G-protein-coupled receptor (GPCRs) like CRHR1, HTR1A and PAQR8.
CC       Interacts with RAMP3. Interacts with KRT7 and KRT8. Interacts with
CC       EGFR; the interaction increases after agonist-induced stimulation in
CC       cancer-associated fibroblasts (CAF). Interacts with EGFR and ESR1 (By
CC       similarity). Interacts (via C-terminus tail motif) with DLG4 (via N-
CC       terminus tandem pair of PDZ domains); the interaction is direct and
CC       induces the increase of GPER1 protein levels residing at the plasma
CC       membrane surface in a estradiol-independent manner. {ECO:0000250,
CC       ECO:0000269|PubMed:23300088, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm, perinuclear
CC       region {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:22919059}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:22919059}. Cytoplasmic
CC       vesicle membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}. Cell membrane; Multi-pass membrane protein. Basolateral
CC       cell membrane; Multi-pass membrane protein. Endoplasmic reticulum
CC       membrane {ECO:0000269|PubMed:21242460}; Multi-pass membrane protein
CC       {ECO:0000250}. Early endosome {ECO:0000250}. Recycling endosome
CC       {ECO:0000250}. Golgi apparatus, trans-Golgi network {ECO:0000250}.
CC       Golgi apparatus membrane {ECO:0000269|PubMed:21242460,
CC       ECO:0000269|PubMed:22919059}; Multi-pass membrane protein. Cell
CC       projection, dendrite. Cell projection, dendritic spine membrane
CC       {ECO:0000269|PubMed:22919059, ECO:0000269|PubMed:23300088}; Multi-pass
CC       membrane protein. Cell projection, axon {ECO:0000269|PubMed:22919059}.
CC       Postsynaptic density {ECO:0000269|PubMed:22919059,
CC       ECO:0000269|PubMed:23300088}. Mitochondrion membrane
CC       {ECO:0000269|PubMed:22919059}; Multi-pass membrane protein.
CC       Note=Endocytosed in an agonist- and arrestin-independent manner.
CC       Colocalized with RAMP3 and clathrin-coated pits at the plasma membrane.
CC       Colocalized with transferrin receptor at the plasma membrane and
CC       perinuclear region. Accumulated and colocalized with RAB11 proteins in
CC       recycling endosomes and trans-Golgi network (TGN), but does neither
CC       recycle back to the cell surface nor traffics to late endosome or
CC       lysosome. Colocalized with calnexin in the endoplasmic reticulum.
CC       Traffics to intracellular sites via cytokeratin intermediate filaments
CC       like KRT7 and KRT8 after constitutive endocytosis in epithelial cells.
CC       Colocalized with EGFR in the nucleus of agonist-induced cancer-
CC       associated fibroblasts (CAF) (By similarity). Colocalized with BSN to
CC       the active zone of presynaptic density. Colocalized with DLG4/PSD95 and
CC       neurabin-2 PPP1R9B in neuronal synaptosomes. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain. Expressed in neurons of the
CC       hippocampus, hypothalamic paraventricular nucleus (PVN), supraoptic
CC       nucleus (SON) and the median eminence. Expressed in magnocellular
CC       neurosecretory cells (MNCs) which secrete oxytocin but not in MNCs
CC       which secrete vasopressin. Expressed in glial cells. Expressed in the
CC       nucleus ambiguous. Expressed in epithelial cells, in pachytene
CC       spermatocytes (PS) (at protein level). Expressed strongly in vascular
CC       endothelial cells and poorly in vascular smooth muscle cells (VSMC).
CC       Expressed in the brain, lung, pituitary gland, adrenal medulla, renal
CC       pelvis and ovary. Expressed in CA1 hippocampus. Expressed weakly in
CC       heart, skeletal muscle and kidney. {ECO:0000269|PubMed:17872373,
CC       ECO:0000269|PubMed:19420011, ECO:0000269|PubMed:20132863,
CC       ECO:0000269|PubMed:21242460, ECO:0000269|PubMed:21354433,
CC       ECO:0000269|PubMed:22919059, ECO:0000269|PubMed:23283935,
CC       ECO:0000269|PubMed:23300088, ECO:0000269|PubMed:9168987}.
CC   -!- PTM: Ubiquitinated; ubiquitination occurs at the plasma membrane and
CC       leads to proteasome-mediated degradation. {ECO:0000250}.
CC   -!- PTM: Glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U92802; AAC53208.1; -; mRNA.
DR   PIR; JC5509; JC5509.
DR   RefSeq; NP_598257.1; NM_133573.1.
DR   AlphaFoldDB; O08878; -.
DR   SMR; O08878; -.
DR   STRING; 10116.ENSRNOP00000001732; -.
DR   BindingDB; O08878; -.
DR   ChEMBL; CHEMBL3309103; -.
DR   GlyCosmos; O08878; 2 sites, No reported glycans.
DR   GlyGen; O08878; 2 sites.
DR   PhosphoSitePlus; O08878; -.
DR   PaxDb; 10116-ENSRNOP00000001732; -.
DR   GeneID; 171104; -.
DR   KEGG; rno:171104; -.
DR   UCSC; RGD:619845; rat.
DR   AGR; RGD:619845; -.
DR   CTD; 2852; -.
DR   RGD; 619845; Gper1.
DR   eggNOG; ENOG502QU56; Eukaryota.
DR   InParanoid; O08878; -.
DR   OrthoDB; 3950227at2759; -.
DR   PhylomeDB; O08878; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:O08878; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0043679; C:axon terminus; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0043198; C:dendritic shaft; IDA:UniProtKB.
DR   GO; GO:0044327; C:dendritic spine head; IDA:UniProtKB.
DR   GO; GO:0032591; C:dendritic spine membrane; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; ISO:RGD.
DR   GO; GO:0045095; C:keratin filament; ISS:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; ISS:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:1903924; F:estradiol binding; IMP:RGD.
DR   GO; GO:0038054; F:G protein-coupled estrogen receptor activity; IDA:UniProtKB.
DR   GO; GO:0030284; F:nuclear estrogen receptor activity; ISO:RGD.
DR   GO; GO:0005496; F:steroid binding; ISO:RGD.
DR   GO; GO:1990239; F:steroid hormone binding; ISS:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030263; P:apoptotic chromosome condensation; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0071389; P:cellular response to mineralocorticoid stimulus; IDA:UniProtKB.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0030520; P:estrogen receptor signaling pathway; IMP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0010948; P:negative regulation of cell cycle process; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0002695; P:negative regulation of leukocyte activation; ISS:UniProtKB.
DR   GO; GO:0051055; P:negative regulation of lipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0019228; P:neuronal action potential; ISS:UniProtKB.
DR   GO; GO:0030264; P:nuclear fragmentation involved in apoptotic nuclear change; IDA:UniProtKB.
DR   GO; GO:0030518; P:nuclear receptor-mediated steroid hormone signaling pathway; IDA:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000724; P:positive regulation of cardiac vascular smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045745; P:positive regulation of G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0001956; P:positive regulation of neurotransmitter secretion; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IDA:RGD.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IMP:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0070474; P:positive regulation of uterine smooth muscle contraction; ISS:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISS:UniProtKB.
DR   GO; GO:0007210; P:serotonin receptor signaling pathway; IMP:RGD.
DR   GO; GO:0043401; P:steroid hormone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; IDA:GO_Central.
DR   CDD; cd14989; 7tmA_GPER1; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR047143; GPER1-like.
DR   PANTHER; PTHR24226:SF2; G-PROTEIN COUPLED ESTROGEN RECEPTOR 1; 1.
DR   PANTHER; PTHR24226; G-PROTEIN COUPLED RECEPTOR 182 AND ESTROGEN RECEPTOR 1; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; Cell cycle; Cell membrane; Cell projection;
KW   Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Differentiation;
KW   Disulfide bond; Endoplasmic reticulum; Endosome;
KW   G-protein coupled receptor; Glycoprotein; Golgi apparatus; Immunity;
KW   Inflammatory response; Innate immunity; Membrane; Mitochondrion;
KW   Neurogenesis; Nucleus; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Synapse; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..375
FT                   /note="G-protein coupled estrogen receptor 1"
FT                   /id="PRO_0000069312"
FT   TOPO_DOM        1..62
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        63..84
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        85..96
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        97..120
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        121..132
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        133..153
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        154..175
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        176..194
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        195..220
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        221..236
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        237..259
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        260..280
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        281..306
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        307..327
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        328..375
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99527"
FT   CARBOHYD        32
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        130..207
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   375 AA;  42260 MW;  08B60576B0DBE314 CRC64;
     MAATTPAQDV GVEIYLGPVW PAPSNSTPLA LNLSLALRED APGNLTGDLS EHQQYVIALF
     LSCLYTIFLF PIGFVGNILI LVVNISFREK MTIPDLYFIN LAAADLILVA DSLIEVFNLD
     EQYYDIAVLC TFMSLFLQIN MYSSVFFLTW MSFDRYLALA KAMRCGLFRT KHHARLSCGL
     IWMASVSATL VPFTAVHLRH TEEACFCFAD VREVQWLEVT LGFIVPFAII GLCYSLIVRA
     LIRAHRHRGL RPRRQKALRM IFAVVLVFFI CWLPENVFIS VHLLQWAQPG DTPCKQSFRH
     AYPLTGHIVN LAAFSNSCLS PLIYSFLGET FRDKLRLYVA QKTSLPALNR FCHATLKAVI
     PDSTEQSDVK FSSAV
//
